Skip to content
LifeAire Systems
Menu
  • Solutions
    • In Vitro Fertilization (IVF)
    • Healthcare & Hospitals
    • Long Term Care
    • Life Sciences & Cell Gene Therapy
    • Commercial & Public Venues
    • Dentistry
    • COVID-19
  • Products
    • Products Overview
    • Aire~HCX | Hospitals & Healthcare
    • Aire~IVF | In Vitro Fertilization
    • Aire~LSX | Life Science
    • Aire~LTCX | Long Term Care
    • Aire~Purity | Commercial Applications
    • Aire~VOC | Volatile Organic Compounds
    • Aire~Secure | In Room Air Purification
    • Aire~BioLite | UV Air Disinfection
    • Aire~BioMid | UV Air Disinfection
    • Aire~LifeLine | In-Line Gas Filtration
    • Patents
  • Services
    • Services Overview
    • Aire~Design™
    • Aire~Analysis
  • Learn
    • News
    • Research and Resources
  • About
    • The LifeAire Story
    • The LifeAire Difference for IVF Patients
    • Leadership
    • Advisors
    • LifeAire Centers of Excellence
    • Patents
    • Customer Testimonials
    • Our Pure Air Guarantee
  • Contact Us

Day: May 15, 2019

Research

The Effects of Air Purification Technology on Clinical and Economic Outcomes

2019

Presented at Keystone Chapter of American College of Surgeons Annual Meeting

Research

Modeling of airborne embryonic volatile compounds (VOCs) in the IVF culture environment – their concomitant cytotoxic concentration within the growth media and embryo.

2019  |  Worrilow, K. C., A. R. Urrutia, H. T. Huynh, J. T. Fox.

Fertility and Sterility

© 2025 LifeAire Systems, LLC | All rights reserved. | Privacy Policy
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset